BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33505538)

  • 1. Expression of Glutamine Metabolism-Related and Amino Acid Transporter Proteins in Adrenal Cortical Neoplasms and Pheochromocytomas.
    Kim HM; Koo JS
    Dis Markers; 2021; 2021():8850990. PubMed ID: 33505538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Glucose Metabolism-Related Proteins in Adrenal Neoplasms.
    Kim EK; Kim HM; Koo JS
    Pathobiology; 2021; 88(6):424-433. PubMed ID: 34518477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation.
    Kamai T; Murakami S; Arai K; Nishihara D; Uematsu T; Ishida K; Kijima T
    BMC Cancer; 2022 Mar; 22(1):289. PubMed ID: 35300626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy-Related Proteins Are Differentially Expressed in Adrenal Cortical Tumor/Pheochromocytoma and Associated with Patient Prognosis.
    Kim HM; Koo JS
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer.
    Kim S; Kim DH; Jung WH; Koo JS
    Endocr Relat Cancer; 2013 Jun; 20(3):339-48. PubMed ID: 23507704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EMP 1, 2, and 3 in Adrenal Cortical Neoplasm and Pheochromocytoma.
    Cha YJ; Koo JS
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
    Wachtel H; Hutchens T; Baraban E; Schwartz LE; Montone K; Baloch Z; LiVolsi V; Krumeich L; Fraker DL; Nathanson KL; Cohen DL; Fishbein L
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4661-70. PubMed ID: 32877928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient suffered from not only MSI-H colon cancer but also adrenal pheochromocytoma.
    Chen YL; Yang LS; Zhang H; Sun SH
    Kaohsiung J Med Sci; 2018 Jan; 34(1):67-69. PubMed ID: 29310819
    [No Abstract]   [Full Text] [Related]  

  • 9. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
    Rajan S; Zaidi G; Agarwal G; Mishra A; Agarwal A; Mishra SK; Bhatia E
    World J Surg; 2016 Mar; 40(3):690-6. PubMed ID: 26438242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
    Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
    Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
    Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
    Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
    Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
    Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
    Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
    Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
    Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
    Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.
    Udager AM; Magers MJ; Goerke DM; Vinco ML; Siddiqui J; Cao X; Lucas DR; Myers JL; Chinnaiyan AM; McHugh JB; Giordano TJ; Else T; Mehra R
    Hum Pathol; 2018 Jan; 71():47-54. PubMed ID: 29079178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas.
    Castelblanco E; Santacana M; Valls J; de Cubas A; Cascón A; Robledo M; Matias-Guiu X
    Endocr Pathol; 2013 Dec; 24(4):199-205. PubMed ID: 24096807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Amine Oxidase Proteins in Adrenal Cortical Neoplasm and Pheochromocytoma.
    Kim EK; Koo JS
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
    Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
    Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
    Stenman A; Zedenius J; Juhlin CC
    Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.